November 23, 1999 10:23
ADM Tronics Announces Aurex-3 Medical Device for Treatment of Tinnitus Approved Under European Medical Device Directive
Jump to first matched term
NORTHVALE, NJ--(BW HEALTHWIRE)--Nov. 23, 1999--
Delivery of Aurex-3 in Europe to Commence During December 1999
ADM Tronics Unlimited, Inc. (OTCBB-ADMT) today announced that the Aurex-3(R) Medical Device for the treatment and control of tinnitus has been approved under the European Medical Device Directive 93/42/EEC. ADM Tronics is now authorized to apply the CE mark to its product. This is a requirement for all medical devices distributed throughout the 15 countries comprising the European Union.
Tinnitus is the medical term for a hearing condition commonly referred to as "ringing in the ears" which ranges in severity from mild to debilitating. It has been reported that there are more than 25 million people in Europe suffering with some degree of tinnitus. Dr. Alfonso Di Mino, President of ADM Tronics and inventor of the Aurex-3, stated, "We are very excited about this approval because it allows us to launch marketing of the Aurex-3 to tinnitus sufferers throughout Europe."
ADM Tronics is a technology based developer and manufacturer of a diversified line of products categorized into three distinct market segments - therapeutic, non-invasive electronic medical devices, environmentally safe chemical products and innovative topical dermatological products.
Statements contained in this press release that are not historical facts are forward looking statements, as defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties, detailed in the Company's filings with the Securities and Exchange Commission, that could cause actual results to differ materially from estimated results.
CONTACT: Andre' Di Mino
201-767-6040,
Fax: 201-784-0620,
e-mail: andre@admtronics.com |
